Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
Lees, A J
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. [electronic resource] - BMJ (Clinical research ed.) Dec 1995 - 1602-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0959-8138
10.1136/bmj.311.7020.1602 doi
Antiparkinson Agents--adverse effects
Benserazide--administration & dosage
Bromocriptine--administration & dosage
Cause of Death
Disability Evaluation
Drug Administration Schedule
Drug Therapy, Combination
Follow-Up Studies
Humans
Levodopa--administration & dosage
Monoamine Oxidase Inhibitors--administration & dosage
Parkinson Disease--drug therapy
Proportional Hazards Models
Prospective Studies
Selegiline--administration & dosage
Time Factors
Treatment Failure
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom. [electronic resource] - BMJ (Clinical research ed.) Dec 1995 - 1602-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0959-8138
10.1136/bmj.311.7020.1602 doi
Antiparkinson Agents--adverse effects
Benserazide--administration & dosage
Bromocriptine--administration & dosage
Cause of Death
Disability Evaluation
Drug Administration Schedule
Drug Therapy, Combination
Follow-Up Studies
Humans
Levodopa--administration & dosage
Monoamine Oxidase Inhibitors--administration & dosage
Parkinson Disease--drug therapy
Proportional Hazards Models
Prospective Studies
Selegiline--administration & dosage
Time Factors
Treatment Failure